We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00249093
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : April 13, 2007
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:
The aim of the study is to evaluate effects of supplementary oxygen during exercise on dyspnoea and exercise tolerance in COPD-patients given long-time oxygen treatment

Condition or disease Intervention/treatment
COPD Drug: oxygen

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single
Primary Purpose: Diagnostic
Study Start Date : October 2005
Study Completion Date : April 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions


Outcome Measures

Primary Outcome Measures :
  1. dyspnea
  2. exercise tolerance

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD patients (male/female)given long-term oxygen treatment
  • Able to perform two separate walking tests

Exclusion Criteria:

  • Severe heart failure
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00249093


Locations
Norway
Glittreklinikken
Hakadal, Norway, 1485
Sponsors and Collaborators
LHL Helse
The norwegian association for heart and lung patients
Investigators
Principal Investigator: Morten S Ryg, dr philos LHL Helse
More Information

ClinicalTrials.gov Identifier: NCT00249093     History of Changes
Other Study ID Numbers: G25-1
First Posted: November 7, 2005    Key Record Dates
Last Update Posted: April 13, 2007
Last Verified: April 2007